Losartan and irbesartan with ‘unacceptable levels’ of impurity

page that reads "product recall"
The TGA is investigating the contamination of some “sartan” medicines, with batches recalled from pharmacies Some batches of losartan and irbesartan products have been recalled after their sponsors advised the TGA that they had detected unacceptable levels of an azide impurity, known as azidomethyl-biphenyl-tetrazole (AZBT). AZBT is a compound that can form during the manufacture

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacist vs Doctor
Next A new name